According to today’s literature, GM-CSF’s complex mechanisms of action are still not fully elucidated, and may end—contradictorily—in immunostimulation or immunosuppression in different physiological or pathological situations (infection, inflammation, cancer) [87]. This evidence concerns the gene CSF2 and cancer.